BAILEY DON M bought LCTX
February 8, 2024 · Form 4 insider transaction
BAILEY DON M bought 96,155 shares of Lineage Cell Therapeutics, Inc. at $1.04 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
96,155
Price
$1.04
Total value
$100.0K
InsiderBAILEY DON M
Role—
SecurityCommon Shares, no par value
Transaction codeP: Open-market purchase
Transaction dateFebruary 8, 2024
Filing dateFebruary 8, 2024
Shares owned after158,801
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report.